Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAbstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect
10.1002/ajmg.1509 · 2001
Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson’s disease
10.1002/1531-8257(200001)15:1<30::aid-mds1007>3.0.co;2-v · 2000
Animal models of Parkinson’s disease
10.1002/bies.10067 · 2002
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease
10.1093/clinchem/47.6.1102 · 2001
Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine
10.1136/jnnp.53.12.1096 · 1990
Affective disorders and S-adenosylmethionine: a new hypothesis
10.1016/0166-2236(89)90038-6 · 1989
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
10.1038/85906 · 2001
Nerve growth factor-mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1
10.1002/jnr.10123 · 2002
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
10.1001/archneur.55.11.1449 · 1998
DNA methylation in brain development and gliomagenesis
10.2741/1027 · 2003
Alzheimer disease: diagnosis, costs, and dimensions of treatment
10.1097/00002093-200108001-00002 · 2001
Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson’s disease
10.1002/1531-8249(199910)46:4<587::aid-ana6>3.0.co;2-m · 1999
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease
10.1046/j.0022-3042.2001.00676.x · 2002
Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons
10.1097/00001756-200112040-00032 · 2001
DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals
10.1523/jneurosci.21-03-00788.2001 · 2001
Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting
1992
10.1007/s007020050058
10.1007/s007020050058
The expression of acetylated microtubules during axonal and dendritic growth in cerebellar macroneurons which develop in vitro
10.1016/0165-3806(89)90022-9 · 1989
Patients with Alzheimer’s disease have reduced activities in midlife compared with healthy control-group members
10.1073/pnas.061002998 · 2001
Molecular genetics of Parkinson’s disease
2001
Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson’s disease
10.1006/nbdi.2000.0287 · 2000
Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice
10.1007/s002580050019 · 1994
Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer’s disease
10.1007/s007020050094 · 1998
Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment
10.2165/00002512-200118090-00004 · 2001
Homocysteine and stroke
10.1097/00019052-200102000-00015 · 2001
Amyloid, the presenilins and Alzheimer’s disease
10.1016/s0166-2236(96)01030-2 · 1997
Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer’s disease
10.1097/00005072-199609000-00003 · 1996
The molecular biology of Huntington’s disease
10.1017/s0033291799002871 · 2001
Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus
10.1523/jneurosci.22-19-08422.2002 · 2002
Polyglutamine disease: acetyltransferases awry
10.1016/s0960-9822(02)00709-1 · 2002
Oxidative stress and neural dysfunction in Down syndrome
1999
Characteristics of gangliosides including O-acetylated species in growth cone membranes at several developmental stages in rat forebrain
10.1016/0165-3806(94)90004-3 · 1994
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
10.1038/nrd772 · 2002
Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal
10.1046/j.1471-4159.1997.69010273.x · 1997
Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity
10.1523/jneurosci.20-18-06920.2000 · 2000
Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease
10.1523/jneurosci.22-05-01752.2002 · 2002
The etiology of Parkinson’s disease with emphasis on the MPTP story
10.1212/wnl.47.6_suppl_3.153s · 1996
1-Methyl-4-phenyl-pyridinium increases S-adenosyl-L-methionine dependent phospholipid methylation
10.1016/s0091-3057(01)00588-3 · 2001
Identification of cognitive impairment in the elderly: homocysteine is an early marker
10.1159/000017092 · 1999
Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor
10.1093/hmg/11.17.1967 · 2002
Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD
10.1212/wnl.55.3.437 · doi-reference
Mechanisms of neuronal degeneration in Alzheimer’s disease
10.1016/s0896-6273(00)80115-4 · doi-reference
Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer’s disease patient
10.1007/bf02736773 · doi-reference
S-methylation in motorneuron disease and Parkinson’s disease
10.1016/s0140-6736(89)90538-2 · doi-reference
Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer’s disease
10.1016/s0014-5793(02)02702-3 · doi-reference
Methylated cytosine and the brain: a new base for neuroscience
10.1016/s0896-6273(01)00325-7 · doi-reference
DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain
10.1016/s1534-5807(01)00101-0 · doi-reference
Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study
10.1093/ajcn/71.4.993 · doi-reference
Carrier-mediated membrane transport of folates in mammalian cells
10.1146/annurev.nutr.19.1.91 · doi-reference
The selective vulnerability of nerve cells in Huntington’s disease
10.1046/j.0305-1846.2001.00299.x · doi-reference
Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease
10.1056/nejmoa011613 · doi-reference
Acetylation and phosphorylation of histones and nonhistone chromosomal proteins in neuronal and glial nuclei purified from cerebral hemispheres of developing rat brain
10.1111/j.1471-4159.1986.tb08508.x · doi-reference
CSF-folate levels are decreased in late-onset AD patients
10.1007/s007020170100 · doi-reference
Neuronal apoptosis induced by histone deacetylase inhibitors
10.1016/s0169-328x(98)00210-1 · doi-reference
Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats
10.1093/carcin/16.11.2863 · doi-reference
Differential acetylation of core histones in rat cerebral cortex neurons during development and aging
10.1111/j.1432-1033.1988.tb14099.x · doi-reference
Nerve growth factor stimulates phospholipid methylation in growing neurites
10.1073/pnas.78.12.7797 · doi-reference
Induction of cholinergic and adrenergic differentiation in N-18 cells by differentiation agents and DNA demethylating agents
10.1016/0006-8993(93)90583-9 · doi-reference
A decade of molecular studies of fragile X syndrome
10.1146/annurev.neuro.25.112701.142909 · doi-reference
Brain S-adenosylmethionine levels are severely decreased in Alzheimer’s disease
10.1046/j.1471-4159.1996.67031328.x · doi-reference
Distribution of acetylated alpha-tublin in brain. In situ localization and biochemical characterization
10.1007/bf00340864 · doi-reference
Histone deacetylase inhibitors reduce polyglutamine toxicity
10.1073/pnas.261400698 · doi-reference
Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms
10.1016/s0047-6374(01)00226-3 · doi-reference
Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites
10.1016/s0006-8993(98)00763-x · doi-reference
Accomplices to neuronal death
10.1038/415377a · doi-reference
Establishment and plasticity of neuronal polarity
10.1002/(sici)1097-4547(19990901)57:5<577::aid-jnr1>3.0.co;2-h · doi-reference
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
10.1152/physrev.1997.77.4.1081 · doi-reference
Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death
10.1523/jneurosci.15-09-06239.1995 · doi-reference
Histone deacetylase activity is necessary for oligodendrocyte lineage progression
10.1523/jneurosci.22-23-10333.2002 · doi-reference